{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "62-year-old patient diagnosed with lung adenocarcinoma after supraclavicular lymph node biopsy. History of deep vein thrombosis, hypertension, benign prostatic hyperplasia and smoking (20 packyears; quit 20 years ago). Thoracic CT revealed a 46 \u00d7 47 mm mass in the second and sixth segments of the left lung, with multiple metastases in both lungs, with bilateral supraclavicular, subcarinal and hilar lymphadenopathy. Performance status 1 of the Eastern Cooperative Oncology Group (ECOG) scale on admission.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Lung adenocarcinoma",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "I80.2",
              "label": "Deep vein thrombosis",
              "status": "historical",
              "onset_date": null
            },
            {
              "code": "I10",
              "label": "Hypertension",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "N40",
              "label": "Benign prostatic hyperplasia",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C77.9",
              "label": "Lymphadenopathy",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C79.9",
              "label": "Secondary malignant neoplasm of unspecified site",
              "status": "active",
              "onset_date": null
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "20 packyears; quit 20 years ago"
            }
          ],
          "imaging": [
            {
              "type": "Neoplasm",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "46 \u00d7 47 mm mass in the second and sixth segments of the left lung, with multiple metastases in both lungs, with bilateral supraclavicular, subcarinal and hilar lymphadenopathy",
              "impression": "Lung adenocarcinoma with metastases",
              "date": null
            }
          ],
          "functional_status": [
            {
              "domain": "general",
              "description": "Performance status 1 of the Eastern Cooperative Oncology Group (ECOG) scale",
              "score": "1",
              "scale": "Eastern Cooperative Oncology Group (ECOG) scale"
            }
          ]
        }
      },
      "custom_id": "graph_037_N0"
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient complains of dyspnea on exertion and dry cough for two months. Reports a weight loss of 4 kg over six months. Auscultation reveals basilar crackles on the left side. Adenocarcinoma diagnosis confirmed (CKAE/AE3+, CK7+, TTF-1+).",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient complains of dyspnea on exertion and dry cough.",
              "duration": "2 months"
            },
            {
              "summary": "Reports a weight loss of 4 kg",
              "duration": "6 months"
            }
          ],
          "diagnoses": [
            {
              "code": "C0001672",
              "label": "Adenocarcinoma",
              "status": "active"
            }
          ],
          "ROS": [
            {
              "system": "respiratory",
              "findings": [
                "Dyspnea on exertion",
                "Dry cough"
              ]
            }
          ]
        }
      },
      "custom_id": "graph_037_N1"
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "EGFR variant testing (cobasEGFRmutation test v2 assay) was negative. ALK protein expression immunohistochemistry (VENTANA ALK CloneD5F3) was negative. ROS1 rearrangement FISH (ZytoLight FISH-Tissue Implementation Kit and SpecROS1Dual Color Break Apart Probe) was negative.",
        "clinical_data": {
          "labs": [
            {
              "test": "cobasEGFRmutation test v2 assay",
              "value": "negative"
            },
            {
              "test": "VENTANA ALK CloneD5F3",
              "value": "negative"
            },
            {
              "test": "ZytoLight FISH-Tissue Implementation Kit and SpecROS1Dual Color Break Apart Probe",
              "value": "negative"
            }
          ]
        }
      },
      "custom_id": "graph_037_N2"
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "PD-L1 expression on 20% of tumor cells (TPS) using Ventana antibody. Thoracic, abdominal, and pelvic CT with contrast (RECIST 1.1 criteria): Target lesions: tumor in left hilum 46 mm, right hilar lymph nodes 47 mm and celiac lymph node 17 mm, SLD 110 mm. Nontarget lesions: enlarged subcarinal, upper and lower paratracheal lymph nodes; multiple lung nodules; ground glass opacities, septal thickening, and small nodules with perilymphatic distribution.",
        "clinical_data": {
          "labs": [
            {
              "test": "PD-L1 expression",
              "value": "20%",
              "unit": "%",
              "flag": "unknown"
            }
          ],
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "Thorax, abdomen, and pelvis",
              "modality": "CT",
              "finding": "Tumor in left hilum 46 mm, right hilar lymph nodes 47 mm and celiac lymph node 17 mm, SLD 110 mm. Enlarged subcarinal, upper and lower paratracheal lymph nodes; multiple lung nodules; ground glass opacities, septal thickening, and small nodules with perilymphatic distribution.",
              "impression": "RECIST 1.1 criteria",
              "date": null
            }
          ]
        }
      },
      "custom_id": "graph_037_N3"
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Subsegmental pulmonary embolism revealed. Started on an anticoagulant. Cranial CT revealed no abnormalities. Disease clinical stage initially classified as IVA (cT2bN3M1a) by 8th Edition of TNM UICC.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0034468",
              "label": "Pulmonary Embolism",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "C0205031",
              "body_part": "C0034467",
              "modality": "CT",
              "finding": "no abnormalities",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "anticoagulant",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0034468"
            }
          ]
        }
      },
      "custom_id": "graph_037_N4"
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient started on immunochemotherapy with cisplatin, pemetrexed, and pembrolizumab for 4 induction courses, followed by pembrolizumab and pemetrexed continuation.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0008833",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1637520",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1710507",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1710507",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1637520",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      },
      "custom_id": "graph_037_N5"
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Thoracic CT scan after 3 months of treatment showed a partial response (SLD 63 mm). Treatment continued for a total of 11 courses.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Thorax",
              "modality": "CT",
              "finding": "Partial response",
              "date": null
            }
          ],
          "procedures": [
            {
              "name": "Treatment",
              "date": null,
              "outcome": "Partial response"
            }
          ]
        }
      },
      "custom_id": "graph_037_N6"
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Subsequent CT scans (every 3 months) showed a partial response (SLD 63 mm) then progressive disease (SLD 76 mm).",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "abdomen",
              "modality": "CT",
              "finding": "partial response",
              "impression": "partial response",
              "date": null
            },
            {
              "type": "CT scan",
              "body_part": "abdomen",
              "modality": "CT",
              "finding": "progressive disease",
              "impression": "progressive disease",
              "date": null
            }
          ]
        }
      },
      "custom_id": "graph_037_N7"
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Treatment with cisplatin, pemetrexed, and pembrolizumab discontinued due to progressive disease. Supraclavicular biopsy performed with RNA-based targeted NGS analysis (FusionPlex\u00aeLung v2). EGFR exon 19 variant detected (NM_005228.5:c.2236_2253delinsATT p.Glu746_Thr751delinsIle). No ALK; NTRK1; NTRK2; NTRK3; RET; ROS1 fusions; MET exon 14 skipping; BRAF, ERBB2, KRAS single-nucleotide polymorphisms; or insertions/deletions observed.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0008767",
              "indication": "C0009450",
              "end_date": null
            },
            {
              "drug": "C1635635",
              "indication": "C0009450",
              "end_date": null
            },
            {
              "drug": "C1874204",
              "indication": "C0009450",
              "end_date": null
            }
          ],
          "procedures": [
            {
              "name": "C0162682",
              "location": "C0038729",
              "date": null
            }
          ],
          "diagnoses": [
            {
              "code": "EGFR",
              "label": "EGFR exon 19 variant",
              "status": "active"
            }
          ]
        }
      },
      "custom_id": "graph_037_N8"
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Patient started",
        "clinical_data": {}
      },
      "custom_id": "graph_037_N9"
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Progression of lung adenocarcinoma with new symptoms.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0013404",
            "C0010200",
            "C0042521"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      },
      "custom_id": "graph_037_N1_N2"
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Molecular testing performed to assess suitability for targeted therapies.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "cobasEGFRmutation test v2 assay",
            "VENTANA ALK CloneD5F3",
            "ZytoLight FISH-Tissue Implementation Kit and SpecROS1Dual Color Break Apart Probe"
          ],
          "change_type": "addition",
          "target_domain": "lab"
        }
      },
      "custom_id": "graph_037_N2_N3"
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Further characterization of tumor with PD-L1 expression and CT imaging for staging.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "PD-L1 expression"
          ],
          "change_type": "addition",
          "target_domain": "lab"
        }
      },
      "custom_id": "graph_037_N3_N4"
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Pulmonary embolism detected, requiring anticoagulation. Staging revised.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0034468"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_037_N4_N5"
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Initiation of immunochemotherapy with cisplatin, pemetrexed, and pembrolizumab.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0008833",
            "C1637520",
            "C1710507"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_037_N5_N6"
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Partial response to immunochemotherapy observed on CT scan.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "Computed tomography"
          ],
          "change_type": "resolution",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_037_N6_N7"
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Initial partial response followed by progressive disease.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "Computed tomography"
          ],
          "change_type": "progression",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_037_N7_N8"
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Treatment discontinued due to progressive disease. Supraclavicular biopsy and NGS analysis revealed EGFR exon 19 variant.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0162682"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_037_N8_N9"
    }
  ]
}